Contact this trialFirst, we need to learn more about you.
Amylin Analog
CagriSema for Type 2 Diabetes and Obesity
Recruiting3 awardsPhase 3
London, Ontario
This trial will study a new medicine to help people with type 2 diabetes and excess body weight to lose weight. Participants will be chosen at random to receive the medicine or a dummy. Women cannot take part if pregnant or planning to be.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.